Events

Bio Integrates 2021

20 May 2021

Nathalie Huther (Senior Director of Business Development, Europe) of Arcinova, a Quotient Sciences business, will be joining the panel discussion "It ain’t what you do, it’s the way that you do it” on 20th May: Networking session 2.

This roundtable discussion will explore how CDMOs can differentiate their offering in a market place where offerings appear similar. The discussion will also explore how biotech companies chose the right one to work with.

Event Details:

Event: Bio Integrates
Date: May 20th, 2021
Location: Virtual event
Conference Website

Resources

See our related resources

Whitepaper

Assessing the Financial Impact of Translational Pharmaceutics®

Tufts Center for the Study of Drug Development (CSDD) white paper sharing study results that indicate Quotient Sciences’ Translational Pharmaceutics® platform reduces development times by more than 12 months and lowers R&D costs by more than $100 million per approved new drug, compared to traditional multi-vendor development paradigms.

Info Sheet

Translational Pharmaceutics

Quotient Sciences helps you achieve your goals by enabling precise formulation development, streamlined manufacturing, quick pivot to clinical data and a significantly faster transition through drug development.

Info Sheet

First-in-Human to Proof-of-Concept

Our Translational Pharmaceutics approach enables First-in-Human studies by re-engineering the transition of your drug molecule into clinical development and shortening the timeline to Proof-of-Concept.

Drug Substance Formulation Development Clinical Trial Manufacturing Commercial Manufacturing Clinical Pharmacology Bioanalysis Data Sciences Drug Development Consulting

Ask us a question

We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.

Suggested searches